Ronald Rodriguez, M.D., Ph.D.

Dr. Ronald Rodriguez received his BS degree in Life Sciences from the Massachusetts Institute of Technology (MIT) in 1984. He obtained his Ph.D. in Cell Biology from Baylor College of Medicine in 1990, and his MD from Baylor College of Medicine in 1992 as part of the Medical Scientist Training Program. After medical school, Dr. Rodriguez entered Johns Hopkins University School of Medicine in 1992 and completed his residency and fellowship training in 1998. He subsequently stayed on faculty at Johns Hopkins from 1999-2012. During his last seven years at Johns Hopkins, he was the program director for urology training. In January 2013, he left Johns Hopkins to become the Henry B. and Edna Smith Dielmann Memorial Professor of Urologic Science at the UTHSCSA. Dr. Rodriguez is a highly experienced urologic surgeon with expertise in urologic oncology, particularly focusing on prostate and kidney cancer. He is a world expert in the use of cryoablative technologies for kidney and recurrent prostate cancer. He is also an expert in the care of urologic cancer patients, including kidney, prostate, bladder, testes and adrenal cancers.  He also takes care of general office urology, hypogonadism (low testosterone), sexual dysfunction and urinary difficulties.  In addition to his clinical practice, he maintains an active research laboratory with interests in the role of oxidative damage in the development of aggressive kidney cancer, immune regulation of kidney cancer, health disparities research, community outreach particularly with education of underserved students, and the use of IT tools for enhancing patient care.  More recently he has turned attention to studying SARS-CoV2 and strategies for its treatment.